TRACON Pharmaceuticals Inc.

07/01/2024 | Press release | Distributed by Public on 07/01/2024 07:17

TRACON Pharmaceuticals Announces Termination of ENVASARC Trial and Will Explore Strategic Alternatives Leveraging its In-House Product Development Platform

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.